You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Open full size image KEY POINTS Exercise therapy is a pleiotropic intervention with the potential to prevent/reverse therapy-related cardiotoxicity across the cancer continuum Patients at high cardiovascular risk according to American Society of Clinical Oncology (ASCO) guidelines may need clearance…
Open full size image KEY POINTS Current and former heavy smokers and patients with respiratory symptoms should be screened for the presence of pulmonary disease at the time of cancer diagnosis Smoking cessation improves treatment outcomes in patients with cancer…
Open full size image KEY POINTS Hypertension and renal disease, which are common in patients with cancer, can have a significant impact on outcomes, including induction and aggravation of cardiotoxicity Baseline risk factors for hypertension and renal disease/toxicity should be…
Open full size image KEY POINTS All patients with cancer should be evaluated for the presence and risk of developing arrhythmias because these can significantly complicate treatments and outcomes The intake should include preexisting atrial fibrillation, QTc prolongation, and cardiac…
Open full size image KEY POINTS Patients with cancer account for more than 20% of all newly diagnosed cases of venous thromboembolic events (VTEs); they are six times more likely to develop VTEs Risk factors for VTE in patients with…
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Open full size image KEY POINTS All patients should undergo screening for preexisting/concomitant cardiovascular (CV) risk factors, cancer-specific risks for cardiomyopathy, and previous cancer therapy-related risk factors for cardiomyopathy before initiation of cancer treatment. Cardiomyopathy or heart failure (CM/HF) can…
Open full size image KEY POINTS Cardiovascular risks depend on traditional risk factors, cancer type, and type of surgical procedures. Assessment of left ventricular (LV) function should be performed preoperatively in patients who have received potentially cardiotoxic chemotherapies, including but…